NYSE - Delayed Quote USD

Emergent BioSolutions Inc. (EBS)

1.9200 -0.0300 (-1.54%)
At close: April 26 at 4:00 PM EDT
1.9001 -0.02 (-1.04%)
After hours: April 26 at 8:00 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-206,300.0000
-206,300.0000
-34,100.0000
320,200.0000
536,900.0000
Investing Cash Flow
212,300.0000
212,300.0000
-381,300.0000
-224,100.0000
-151,900.0000
Financing Cash Flow
-535,700.0000
-535,700.0000
481,200.0000
-141,000.0000
69,500.0000
End Cash Position
111,700.0000
111,700.0000
642,600.0000
576,300.0000
621,500.0000
Income Tax Paid Supplemental Data
52,800.0000
52,800.0000
6,200.0000
71,600.0000
109,300.0000
Interest Paid Supplemental Data
68,300.0000
68,300.0000
33,000.0000
30,400.0000
21,000.0000
Capital Expenditure
-51,600.0000
-51,600.0000
-115,800.0000
-224,100.0000
-141,900.0000
Issuance of Capital Stock
8,400.0000
8,400.0000
--
--
--
Issuance of Debt
20,000.0000
20,000.0000
598,000.0000
--
450,000.0000
Repayment of Debt
-563,400.0000
-563,400.0000
-33,800.0000
-35,900.0000
-387,100.0000
Repurchase of Capital Stock
--
--
-82,100.0000
-106,000.0000
--
Free Cash Flow
-257,900.0000
-257,900.0000
-149,900.0000
96,100.0000
395,000.0000
12/31/2020 - 11/15/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers